Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,157.50    18.50 (1.62%)
Bid:
1,157.50
Ask:
1,158.00
Spread: 0.50 (0.043%)
Market Cap: £9.83b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

12 Aug 2022 16:45

RNS Number : 9197V
Smith & Nephew Plc
12 August 2022
 

SMITH & NEPHEW PLC

 

12 August 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020

 

On 12 August 2022 the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted under the Smith & Nephew Global Share Plan 2020. The awards have been made in London and are based on the closing Share price on the London Stock Exchange on 11 August 2022 of £10.645.

 

i. CONDITIONAL SHARE AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020:

 

The awards will vest a quarter on 20 May 2023, a quarter on 20 May 2024 and the remaining portion will vest on 20 May 2025 subject to continued achievement of objectives and employment.

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc Ordinary Shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Conditional share awards granted on 12 August 2022 under the Smith & Nephew Global Share Plan 2020.

Date of Transaction

2022 - 08 - 12

Place of Transaction

Grant took place outside a trading venue

 

Name

(Position)

 

Status

Price (s)

Volume(s)

Aggregated information

Myra Eskes

(President APAC and Global Service)

PDMR

£10.645

46,735

N/A Single Transaction

Elga Lohler

(Chief HR Officer)

PDMR

£10.645

40,350

N/A Single Transaction

Vasant Padmanabhan

(President Research & Development)

PDMR

£10.645

39,252

N/A Single Transaction

 

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSETVIFLIF
Date   Source Headline
1st Mar 202212:11 pmRNSTotal Voting Rights
28th Feb 20226:06 pmRNSTransaction in Own Shares
25th Feb 20226:05 pmRNSTransaction in Own Shares
24th Feb 20226:11 pmRNSTransaction in Own Shares
23rd Feb 20226:18 pmRNSTransaction in Own Shares
23rd Feb 20229:00 amRNSDirector/PDMR Shareholding
22nd Feb 202212:30 pmRNSTransaction in Own Shares
22nd Feb 20227:01 amRNSSmith+Nephew announces new Chief Executive Officer
22nd Feb 20227:00 amRNSFinal Results
1st Feb 20224:30 pmRNSBlock listing Interim Review
1st Feb 20221:15 pmRNSTotal Voting Rights
25th Jan 202210:00 amRNSJo Hallas joins Smith+Nephew as NED
25th Jan 20229:00 amRNSNotice of Results
19th Jan 20225:00 pmRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSS+N acquires novel cementless partial knee system
4th Jan 20221:12 pmRNSTotal Voting Rights
16th Dec 202112:00 pmRNSSmith+Nephew outlines ‘Strategy for Growth'
1st Dec 202112:08 pmRNSTotal Voting Rights
17th Nov 20212:00 pmRNSDirector/PDMR Shareholding
12th Nov 20214:30 pmRNSDirector/PDMR Shareholding
4th Nov 20217:00 amRNSTrading Statement
2nd Nov 202110:30 amRNSDirector/PDMR Shareholding
1st Nov 20213:00 pmRNSDirector/PDMR Shareholding
1st Nov 20211:53 pmRNSTotal Voting Rights
29th Oct 202111:45 amRNSDirector/PDMR Shareholding
22nd Oct 20219:00 amRNSSmith+Nephew to host Meet the Management event
15th Oct 20218:47 amRNSDividend Declaration
8th Oct 20219:00 amRNSNotice of Results
1st Oct 202110:16 amRNSTotal Voting Rights
24th Sep 20213:47 pmRNSDirector/PDMR Shareholding
17th Sep 20212:30 pmRNSAdditional Listing
16th Sep 20217:00 amRNSDirector/PDMR Shareholding
14th Sep 20215:00 pmRNSDirector/PDMR Shareholding
1st Sep 202110:59 amRNSTotal Voting Rights
27th Aug 20219:00 amRNSDirector/PDMR Shareholding
24th Aug 202110:30 amRNSDirector/PDMR Shareholding
23rd Aug 20211:00 pmRNSDirector/PDMR Shareholding
17th Aug 202111:15 amRNSDirector/PDMR Shareholding
4th Aug 202111:31 amRNSDirector/PDMR Shareholding
2nd Aug 20212:53 pmRNSBlock listing Interim Review
2nd Aug 202111:24 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSHalf-year Report
19th Jul 20211:00 pmRNSDirector/PDMR Shareholding
7th Jul 20219:00 amRNSNotice of Results
1st Jul 202111:13 amRNSTotal Voting Rights
1st Jun 202111:48 amRNSTotal Voting Rights
25th May 20216:15 pmRNSDirector/PDMR Shareholding
21st May 20214:30 pmRNSDirector/PDMR Shareholding
18th May 20215:15 pmRNSDirector/PDMR Shareholding
14th May 20214:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.